Basking Biosciences is a clinical-stage biopharmaceutical company in Research Triangle, North Carolina (with operations in Mitchelton, Queensland, Australia) developing novel therapies for life-threatening blood clots. Its lead program BB-031 is an investigational RNA aptamer that targets von Willebrand Factor (vWF) to deliver a rapid-onset, targeted, and reversible thrombolytic for acute ischemic stroke, paired with BB-025, a direct-acting reversal agent designed to rapidly neutralize BB-031. The company is running the RAISE Phase 2 clinical trial and is backed by Insight Partners. Surfaced as a VC portfolio company and added to the API Evangelist network; the company publishes no public developer API, SDK, or documentation surface, so this profile carries company identity only.
Basking Biosciences is profiled on the APIs.io network. Tagged areas include Company, Biotech Therapeutics, Biopharmaceutical, Clinical Stage, and Stroke.
Basking Biosciences’ developer surface includes engineering blog and 7 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: basking-biosciences
deliveryModel:
model: saas
open_source: false
commercial: true
callable_host: false
label: Hosted service · you call their endpoint
confidence: medium
source:
- pricing
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source: []
generated: '2026-07-22'
method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/basking-biosciences.png
name: Basking Biosciences
description: Basking Biosciences is a clinical-stage biopharmaceutical company in Research Triangle, North Carolina (with
operations in Mitchelton, Queensland, Australia) developing novel therapies for life-threatening blood clots. Its lead program
BB-031 is an investigational RNA aptamer that targets von Willebrand Factor (vWF) to deliver a rapid-onset, targeted, and
reversible thrombolytic for acute ischemic stroke, paired with BB-025, a direct-acting reversal agent designed to rapidly
neutralize BB-031. The company is running the RAISE Phase 2 clinical trial and is backed by Insight Partners. Surfaced as
a VC portfolio company and added to the API Evangelist network; the company publishes no public developer API, SDK, or documentation
surface, so this profile carries company identity only.
url: https://raw.githubusercontent.com/api-evangelist/basking-biosciences/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- insight-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-08-10'
tags:
- Company
- Biotech Therapeutics
- Biopharmaceutical
- Clinical Stage
- Stroke
- Thrombosis
- Drug Development
- Life Sciences
apis: []
common:
- type: DomainSecurity
url: security/basking-biosciences-domain-security.yml
- type: Website
url: https://www.baskingbiosciences.com/
- type: About
url: https://www.baskingbiosciences.com/about
- type: Blog
url: https://www.baskingbiosciences.com/news
- type: LinkedIn
url: https://www.linkedin.com/company/basking-biosciences-inc
- type: PrivacyPolicy
url: https://www.baskingbiosciences.com/legal/privacy-policy
- type: TermsOfService
url: https://www.baskingbiosciences.com/legal/terms-of-use
- type: LLMsTxt
url: llms/basking-biosciences-llms.txt
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
x-enrichment:
date: '2026-08-10'
status: minimal
artifacts_added: 4
pass: local-v1
note: Full STEP 0b contract discovery run against every apparent host. No spec, no developer surface, no packages, no GitHub
org. Probed absences recorded in well-known/ and packages/; domain security probed; llms.txt generated.
x-coverage:
state: none
reason: not-a-software-company
detail: Basking Biosciences is a clinical-stage biopharmaceutical company developing the RNA-aptamer thrombolytic BB-031;
its entire web presence is a 20-URL Webflow marketing site (science, programs, publications, news releases, legal) whose
sitemap contains no developer, docs, or API path, and api.baskingbiosciences.com does not resolve in DNS.
evidence:
- url: https://www.baskingbiosciences.com/sitemap.xml
status: 200
- url: https://www.baskingbiosciences.com/openapi.json
status: 404
- url: https://www.baskingbiosciences.com/developers
status: 404
- url: https://www.baskingbiosciences.com/.well-known/agent-card.json
status: 404
- url: https://pypi.org/pypi/basking-biosciences/json
status: 404
checked: '2026-08-10'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →